These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study. McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I; Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R; Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163 [TBL] [Abstract][Full Text] [Related]
10. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis. Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT; Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051 [TBL] [Abstract][Full Text] [Related]
11. The influence of symptom severity and fatigue on sleep quality in patients with myasthenia gravis. Yeşil Demirci P; Eskimez Z; Bozdoğan Yeşilot S Neurol Res; 2024 Jan; 46(1):42-48. PubMed ID: 37700391 [TBL] [Abstract][Full Text] [Related]
12. Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients. Raggi A; Antozzi C; Baggi F; Leonardi M; Maggi L; Mantegazza R Neurol Sci; 2017 Nov; 38(11):1927-1931. PubMed ID: 28780706 [TBL] [Abstract][Full Text] [Related]
13. Translation and validation of the arabic version of the myasthenia gravis activities of daily living scale. Alanazy MH; Abuzinadah AR; Muayqil T Muscle Nerve; 2019 May; 59(5):583-586. PubMed ID: 30697753 [TBL] [Abstract][Full Text] [Related]
14. Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scores. Dewilde S; Janssen MF; Tollenaar NH; Vanoli F; Frangiamore R; Phillips G; Paci S; Mantegazza R; Meisel A; Stascheit F Muscle Nerve; 2023 Jul; 68(1):65-72. PubMed ID: 37144893 [TBL] [Abstract][Full Text] [Related]
15. Physician- and self-assessed myasthenia gravis activities of daily living score. Lee HL; Min JH; Seok JM; Cho EB; Cho HJ; Kim YD; Kim BJ Muscle Nerve; 2018 Mar; 57(3):419-422. PubMed ID: 28796382 [TBL] [Abstract][Full Text] [Related]
16. Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study. Wilcke H; Glaubitz S; Kück F; Anten C; Liebetanz D; Schmidt J; Zschüntzsch J BMC Neurol; 2023 Oct; 23(1):366. PubMed ID: 37817097 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of outcome measures for myasthenia gravis subgroups. Luo Y; Dong X; Peng Y; Cui B; Yan C; Jin W; Li Y; Zhou R; Huang K; Yang H J Clin Neurosci; 2021 Sep; 91():270-275. PubMed ID: 34373039 [TBL] [Abstract][Full Text] [Related]